Lactoferrin: A modulator of immune and inflammatory responses

Cellular and Molecular Life Sciences

Volumn 62, Issue 22, 2005, Pages 2549-2559

  Legrand, D ^a   Elass, E ^a   Carpentier, M ^a   Mazurier, J ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Immunity; Inflammation; Lactoferrin; ROS; Th1

Indexed keywords

GLYCOPROTEIN; IRON BINDING PROTEIN; LACTOFERRIN; MEMBRANE PROTEIN; TRANSFERRIN;

ANTIMICROBIAL ACTIVITY; BODY FLUID; CELL FUNCTION; CELL GRANULE; CELL MATURATION; CELL MIGRATION; DIGESTIVE SYSTEM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; IRON BINDING CAPACITY; MILK; MOLECULAR INTERACTION; NEUTROPHIL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SEPTIC SHOCK;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; LACTOFERRIN;

EID: 28444462150     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5370-2     Document Type: Review

References (125)

1. Montreuil J., Tonnelat J. and Mullet S. (1960) Préparation et propriétés de la lactosidérophiline (lactotransferrine) du lait de femme. Biochim. Biophys. Acta 45: 413-421
2. Teng C. T., Beard C. and Gladwell W. (2002) Differential expression and estrogen response of lactoferrin gene in the female reproductive tract of mouse, rat and hamster. Biol. Reprod. 67: 1439-1449
3. Masson P. L., Heremans J. F. and Schonne E. (1969) Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658
4. Houghton M. R., Gracey M., Burke V., Bottrell C. and Spargo R. M. (1985) Breast milk lactoferrin levels in relation to maternal nutritional status. J. Pediatr. Gastroenterol. Nutr. 4: 230-233
5. Bennett R. M. and Kokocinski T. (1978) Lactoferrin content of peripheral blood cells. Br. J. Haematol. 39: 509-521
6. Maaks S., Yan H. Z. and Wood W. G. (1989) Development and evaluation of luminescence based sandwich assay for plasma lactoferrin as a marker for sepsis and bacterial infections in pediatric medicine. J. Biolumines. Chemilumines. 3: 221-226
7. Debanne M.T., Regoeczi E., Sweeney G.D. and Krestynski F. (1985) Interaction of human lactoferrin with the rat liver. Am. J. Physiol. 248: G463-469
8. Ziere G.J., Kruijt J.K., Bijsterbosch M.K. and Van Berkel T.J. (1996) Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor. Biochem. J. 313: 289-295
9. Mann D. M., Romm E. and Migliorini M. (1994) Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269: 23661-23667
10. Legrand D., van Berkel PH., Salmon V., van Veen H.A., Slomianny M.C., Nuijens J.H. et al. (1997) The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem. J. 327: 841-846
11. Thomas L. L., Xu W. and Ardon T. T. (2002) Immobilized lactoferrin is a stimulus for eosinophil activation. J. Immunol. 169: 993-999
12. Ward P. P. and Conneely O. M. (2004) Lactoferrin: role in iron homeostasis and host defense against microbial infection. Biometals 17:203-208
13. Masson P. L., Heremans J. F. and Schonne E. (1969) Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658
14. Annane D., Bellissant E. and Cavaillon J. M. (2005) Septic shock. Lancet 365: 63-78
15. Rey M. W., Woloshuk S. L., DeBoer H. A. and Pieper F. R. (1990) Complete nucleotide sequence of human mammary gland lactoferrin. Nucl. Acids Res. 18: 5288-5295
16. Anderson B. F. Baker H. M., Dodson E. J., Norris G. E., Rumball S. V., Waters J. M. et al. (1987) Structure of human lactoferrin at 3.2- resolution. Proc. Natl. Acad. Sci. USA 84: 1769-1773
17. Wakabayashi H., Takakura N., Teraguchi S. and Tamura Y. (2003) Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol. Immunol. 47: 37 43
18. Wakabayashi H., Takase M. and Tomita M. (2003) Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 9: 1277-1287
19. Van der Kraan M. I., Groenink J., Nazmi K., Veerman E. C. and Bolscher J. G. (2004) Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25: 177-183
20. Baker H. M., Anderson B. F. and Baker E. N (2003) Dealing with iron: common structural principles in proteins that transport iron and heme. Proc. Natl. Acad. Sci. USA 100: 3579-3583
21. Mazurier J. and Spik G. (1980) Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629: 399-408
22. Anderson B. F., Baker H. M., Norris G. E., Rumball S. V. and Baker E. N. (1990) Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature 344: 784-787
23. Damiens E., El Yazidi I., Mazurier J., Elass-Rochard E., Duthille I., Spik G. et al. (1998) Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line. Eur. J. Cell. Biol. 77: 344-351
24. Van Berkel P. H., Geerts M. E., Van Veen H. A., Mericskay M., de Boer H. A. and Nuijens J. H. (1997) N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 15: 145-151
25. Mazurier J., Legrand D., Hu W. L., Montreuil J. and Spik G. (1989) Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Eur. J. Biochem. 179: 481-487
26. Leveugle B., Mazurier J., Legrand D., Mazurier C., Montreuil J. and Spik G. (1993) Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem. 213: 1205-1211
27. Damiens E., Mazurier J., El Yazidi I., Masson M., Duthille I., Spik G. et al. (1998) Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim. Biophys. Acta 1402: 277-287
28. Legrand D., Vigie K., Said E. A., Elass E., Masson M., Slomianny M. C. et al. (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 271: 303-317
29. Grey A., Banovic T., Zhu Q., Watson M., Callon K., Palmano K. et al. (2004) The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 18: 2268-2278
30. Ashida K., Sasaki H., Suzuki Y.A. and Lönnerdal B. (2004) Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals 17: 311-315
31. Suzuki Y. A. and Lönnerdal B. (2002) Characterization of mammalian receptors for lactoferrin. Biochem. Cell. Biol. 80: 75-80
32. Appelmelk B. J., An Y. Q., Geerts M., Thijs B. G., De Boer H. A., MacLaren D. M. et al. (1994) Lactoferrin is a lipid A-binding protein. Infect. Immun. 62: 2628-2632
33. Brandenburg K., Jurgens G., Muller M., Fukuoka S. and Koch M. H. (2001) Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 382: 1215-1225
34. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C. et al. (1995) Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to E. coli 055B5 lipopolysaccharide. Biochem. J. 312: 839-845
35. Elass-Rochard E., Legrand D., Salmon V., Roseanu A., Trif M., Tobias P. S. et al. (1998) Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 66: 486-491
36. Britigan B. E., Lewis T. S., Waldschmidt M., McCormick M. L. and Krieg A. M. (2001) Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol. 167: 2921-2928
37. Baveye S., Elass E., Fernig D. G., Blanquart C., Mazurier J. and Legrand D. (2000) Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect. Immun. 68: 6519-6525
38. Japelj B. T., Pristov-Ek P., Majerle A. and Jerala R. (2005) Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J. Biol. Chem. Epub ahead of print
39. Chapple D. S., Hussain R., Joannou C. L., Hancock R. E., Odell E., Evans R. W. et al. (2004) Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob. Agents Chemother. 48: 2190-2198
40. Farnaud S., Spiller C., Moriarty L. C., Patel A., Gant V., Odell E. W. et al. (2004) Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiol. Lett. 233: 193-199
41. Dhennin-Duthille I., Masson M., Damiens E., Fillebeen C., Spik G. and Mazurier J. (2000) Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J. Cell. Biochem. 79: 583-593
42. Oh S.M., Hahm D.H., Kim I.H. and Choi S.Y. (2001) Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J. Biol. Chem. 276: 42575-42579
43. Haversen L., Ohlsson B. G., Hahn-Zoric M., Hanson L. A. and Mattsby-Baltzer I. (2002) Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappaB. Cell. Immunol. 220: 83-95
44. Oh S. M., Pyo C. W., Kim Y. and Choi S. Y. (2004) Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene 23: 8282-8291
45. Ward P. P. and Conneely O. M. (2004) Lactoferrin: role in iron homeostasis and host defense against microbial infection. Biometals 17: 203-208.
46. Breton-Gorius J., Mason D. Y., Buriot D., Vilde J.-L. and Griscelli M. D. (1980) Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Am. J. Pathol. 99: 413-428
47. Gordon D., Davis J., Fox P., Malech H., Gallin J., Baraniuk J. et al. (1989) Glandular secretion of lactoferrin in a patient with neutrophil lactoferrin deficiency. J. Allergy Clin. Immunol. 84: 914-919
48. Guillen C., McInnes I. B., Vaughan D. M., Kommajosyula S., Van Berkel P. H., Leung B. P. et al. (2002) Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J. Immunol. 168: 3950-3957
49. Schaible U. E., Collins H. L., Priem F. and Kaufmann S. H. (2002) Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196: 1507-1513
50. Van Hooijdonk A. C. , Kussendrager K. D. and Steijns J. M. (2000) In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br. J. Nutr. 84: S127-134
51. Zagulski T., Lipinski P., Zagulska A., Broniek S. and Jarzabek Z. (1989) Lactoferrin can protect mice against a lethal dose of E. coli in experimental infection in vivo. Br. J. Exp. Pathol. 70: 697-704
52. Ochoa T. J., Noguera-Obenza M., Ebel F., Guzman C. A., Gomez H. F. and Cleary T. G. (2003) Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect. Immun. 71: 5149-5155
53. Takakura N., Wakabayashi H., Ishibashi H., Yamauchi K., Teraguchi S., Tamura Y. et al. (2004) Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J. Med. Microbiol. 53: 495-500
54. Lee W. J., Farmer J. L., Hilty M. and Kim Y. B. (1998) The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66: 1421-1426
55. Sawatzki G. and Rich I. N. (1989) Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15: 371-385
56. Broxmeyer H. E., Williams D. E., Hangoc G., Cooper S., Gentile P., Shen R. N. et al. (1987) The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells 13: 31-48
57. Machnicki M., Zimecki M. and Zagulski T. (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74: 433-439
58. Kruzel M. L., Harari Y. Mailman D., Actor J. K. and Zimecki M. (2002) Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol. 130: 25-31
59. Togawa J., Nagase H., Tanaka K., Inamori M., Nakajima A., Ueno N. et al. (2002) Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 17: 1291-1298
60. Shimizu K., Matsuzawa H., Okada K., Tazume S., Dosako S., Kawasaki Y. et al. (1996) Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol. 141: 1875-1889
61. Yamauchi K., Wakabayashi H., Hashimoto S., Teraguchi S., Hayasawa H. and Tomita M. (1998) Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv. Exp. Med. Biol. 443: 261-265
62. Szuster-Ciesielska A., Kaminska T. and Kandefer-Szerszen M. (1995) Phagocytosis-enhancing effect of lactoferrin on bovine peripheral blood monocytes in vitro and in vivo. Arch. Vet. Pol. 35: 63-71
63. Kurose I., Yamada T., Wolf R. and Granger D. N. (1994) P-selectin-dependent leukocyte recruitment and intestinal mucosal injury induced by lactoferrin. J. Leukoc. Biol. 55: 771-777
64. Mincheva-Nilsson L., Hammarstrom S. and Hammarstrom M. L. (1997) Activated human gamma delta T lymphocytes express functional lactoferrin receptors. Scand. J. Immunol. 46: 609-618
65. Suzuki Y. A. and Lönnerdal B. (2002) Characterization of mammalian receptors for lactoferrin. Biochem. Cell. Biol. 80: 75-80
66. Zimecki M., Mazurier J., Spik G. and Kapp J. A. (1995) Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86: 122-127
67. Zimecki M., Mazurier J., Machnicki M., Wieczorek Z., Montreuil J. and Spik G. (1991) Immunostimulatory activity of lactotransferrin and maturation of CD4- CD8- murine thymocytes. Immunol. Lett. 30: 119-123
68. Frydecka I., Zimecki M., Bocko D., Kosmaczewska A., Teodorowska R., Ciszak L. et al. (2002) Lactoferrin-induced upregulation of ζ (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res. 22: 1897-1901
69. Deriy L. V., Chor J. and Thomas L. L. (2000) Surface expression of lactoferrin by resting neutrophils. Biochem. Biophys. Res. Commun. 275: 241-246
70. Maneva A. I., Sirakov L. M. and Manev V. V. (1983) Lactoferrin binding to neutrophilic polymorphonuclear leucocytes. Int. J. Biochem. 15: 981-984
71. Afeltra A., Caccavo D., Ferri G. M., Adessi M. A., De Rosa F. G., Amoroso A. et al. (1997) Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin. Exp. Immunol. 109: 279-285
72. Gahr M., Speer C. P., Damerau B. and Sawatzki G. (1991) Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J. Leukoc. Biol. 49: 427-433
73. Shinoda I., Takase M., Fukuwatari Y., Shimamura S., Koller M. and Konig W. (1996) Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Biosci. Biotechnol. Biochem. 60: 521-523
74. Sorimachi K., Akimoto K., Hattori Y., Leiri T. and Niwa A. (1997) Activation of macrophages by lactoferrin: secretion of TNF-α, IL-8 and NO. Biochem. Mol. Biol. Int. 43: 79-87
75. Kai K., Komine K., Komine Y., Kuroishi T., Kozutsumi T., Kobayashi J. et al. (2002) Lactoferrin stimulates A Staphylococcus aureus killing activity of bovine phagocytes in the mammary gland. Microbiol. Immunol. 46: 187-194
76. Kijlstra A. and Jeurissen S. H. (1982) Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology 47: 263-270
77. Rainard P. (1993) Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Immunology 79: 648-652
78. Samuelsen O., Haukland H. H., Ulvatne H. and Vorland L. H. (2004) Anti-complement effects of lactoferrin-derived peptides. FEMS Immunol. Med. Microbiol. 41: 141-148
79. Miyauchi H., Hashimoto S., Nakajima M., Shinoda I., Fukuwatari Y. and Hayasawa H. (1998) Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell. Immunol. 187: 34-37
80. Zimecki M., Kocieba M. and Kruzel M. (2002) Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology 205: 120-131
81. Hwang S. A., Kruzel M. L. and Actor J. K. (2005) Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis. Int. Immunopharmacol. 5: 591-599
82. Groot F., Geijtenbeek T. B., Sanders R. W., Baldwin C. E., Sanchez-Hernandez M., Floris R. et al. (2005) Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79: 3009-3015
83. Miyazawa K., Mantel C., Lu L., Morrison D. C. and Broxmeyer H. E. (1991) Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J. Immunol. 146: 723-729
84. Crouch S. P., Slater K. J. and Fletcher J. (1992) Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1: 235-240
85. Mattsby-Baltzer I., Roseanu A., Motas C., Elverfors J., Engberg I. and Hanson L. A. (1996) Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40: 257-262
86. Zimecki M., Dawiskiba J., Zawirska B., Krawczyk Z. and Kruzel M. (2003) Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats. Inflamm. Res. 52: 305-310
87. Zhang G. H., Mann D. M. and Tsai C. M. (1999) Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 67: 1353-1358
88. Baveye S., Elass E., Mazurier J. and Legrand D. (2000) Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett. 469: 5-8
89. Elass E., Masson M., Mazurier J. and Legrand D. (2002) Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70: 1860-1866
90. Guillen C., McInnes I. B., Vaughan D., Speekenbrink A. B. and Brock J. H. (2000) The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum. 43: 2073-2080
91. Hayashida K., Kaneko T., Takeuchi T., Shimizu H., Ando K. and Harada E. (2004) Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci. 66: 149-154
92. Sasaki Y., Otsuki K., Hasegawa A., Sawada M., Chiba H., Negishi M. et al. (2004) Preventive effect of recombinant human lactoferrin on lipopolysaccharide-induced preterm delivery in mice. Acta. Obstet. Gynecol. Scand. 83: 1035-1038
93. Sano H., Nagai K., Tsutsumi H. and Kuroki Y. (2003) Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol. 33: 2894-2902
94. Na Y. J., Han S. B., Kang J. S., Yoon Y. D., Park S. K., Kim H. M. et al. (2004) Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int. Immunopharmacol. 4: 1187-1199
95. Artym J., Zimecki M. and Kruzel M. L. (2003) Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology 207: 197-205
96. Artym J., Zimecki M. and Kruzel M. L. (2004) Effects of lactoferrin on IL-6 production by peritoneal and alveolar cells in cyclophosphamide-treated mice. J. Chemother. 16: 187-192
97. Artym J., Zimecki M., Paprocka M. and Kruzel M. L. (2003) Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett. 89: 9-15
98. Wakabayashi H., Kurokawa M., Shin K., Teraguchi S., Tamura Y. and Shiraki K. (2004) Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice. Biosci. Biotechnol. Biochem. 68: 537-544
99. Iigo M., Shimamura M., Matsuda E., Fujita K., Nomoto H., Satoh J. et al. (2004) Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 25: 36-44
100. Shimamura M., Yamamoto Y., Ashino H., Oikawa T., Hazato T., Tsuda H. et al. (2004) Bovine lactoferrin inhibits tumor-induced angiogenesis. Int. J. Cancer. 111: 111-116
101. Ishii K., Takamura N., Shinohara M., Wakui N., Shin H., Sumino Y. et al. (2003) Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months Hepatol. Res. 25: 226-233
102. Dial E. J., Dohrman A. J., Romero J. J. and Lichtenberger L. M. (2005) Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J. Pharm. Pharmacol. 57: 93-99
103. Zimecki M., Artym J., Chodaczek G., Kocieba M. and Kruzel M. L. (2004) Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils. Inflamm. Res. 53: 292-296
104. Fillebeen C., Ruchoux M. M., Mitchell V., Vincent S., Benaïssa M. and Pierce A. (2001) Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res. Mol. Brain Res. 96: 103-113
105. Fillebeen C., Dehouck B., Benaïssa M., Dhennin-Duthille I., Cecchelli R. and Pierce A. (1999) Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier. J. Neurochem. 73: 2491-2500
106. Elrod K. C., Moore W. R., Abraham W. M. and Tanaka R. D. (1997) Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am. J. Respir. Crit. Care Med. 156: 375-381
107. Griffiths C. E., Cumberbatch M., Tucker S. C., Dearman R. J., Andrew S., Headon D. R. et al. (2001) Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br. J. Dermatol. 144: 715-725
108. Zweiman B., Kucich U., Shalit M., Von Allmen C., Moskovitz A., Weinbaum G. et al. (1990) Release of lactoferrin and elastase in human allergic skin reactions. J. Immunol. 144: 3953-3960
109. Cumberbatch M., Bhushan M., Dearman R. J., Kimber I. and Griffiths C. E. (2003) IL-1beta-induced Langerhans cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin. Exp. Immunol. 132: 352-359
110. Kimber I., Cumberbatch M., Dearman R. J., Headon D. R., Bhushan M. and Griffiths C. E. (2002) Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem. Cell. Biol. 80: 103-107
111. He S., McEuen A. R., Blewett S. A., Li P., Buckley M. G., Leufkens P. et al. (2003) The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. Biochem. Pharmacol. 65: 1007-1015
112. He S. H. and Xie H. (2004) Inhibition of tryptase release from human colon mast cells by protease inhibitors. World J. Gastroenterol. 10: 332-336
113. He S. H. and Xie H. (2004) Modulation of histamine release from human colon mast cells by protease inhibitors. World J. Gastroenterol. 10: 337-341
114. Caccavo D., Sebastiani G. D., Di Monaco C., Guido F., Galeazzi M., Ferri G. M. et al. (1999) Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis. Int. J. Clin. Lab. Res. 29: 30-35
115. Reghunathan R., Jayapal M., Hsu L. Y., Chng H. H., Tai D., Leung B. P. et al. (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol. 6: 2
116. Greenberg D. E., Jiang Z. D., Steffen R., Verenker P. and Dupont H. L. (2002) Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J. Infect. Dis. 185: 944-949
117. Qadri F., Alam M. S., Nishibuchi M., Rahman T., Alam N. H., Chisti J. et al. (2003) Adaptive and inflammatory immune responses in patients infected with strains of Vibrio parahaemolyticus. J. Infect. Dis. 187: 1085-1096
118. Kane S. V., Sandborn W. J., Rufo P. A., Zholudev A., Boone J., Lyerly D. et al. (2003) Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenterol. 98: 1309-1314
119. Larsen A., Hovdenak N., Karlsdottir A., Wentzel-Larsen T., Dahl O. and Fagerhol M. K. (2004) Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers. Scand. J. Gastroenterol. 39: 1113-1118
120. Buderus S., Boone J., Lyerly D. and Lentze M. J. (2004) Fecal lactoferrin: a new parameter to monitor infliximab therapy. Dig. Dis. Sci. 49: 1036-1039
121. Esteban M. A., Rodriguez A., Cuesta A. and Meseguer J. (2005) Effects of lactoferrin on non-specific immune responses of gilthead seabream (Sparus auratus L.). Fish Shellfish Immunol. 18:109-124
122. Ishikado A., Imanaka H., Kotani M., Fujita A., Mitsuishi Y., Kanemitsu T. et al. (2004) Liposomal lactoferrin induced significant increase of the interferon-alpha (IFN-alpha) producibility in healthy volunteers. Biofactors 21: 69-72
123. Griffiths E. A., Duffy L. C., Schanbacher F. L., Qiao H., Dryja D., Leavens A. et al. (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig. Dis. Sci. 49: 579-589
124. Kitagawa H., Yoshizawa Y., Yokoyama T., Takeuchi T., Talukder M. J., Shimizu H. et al. (2003) Persorption of bovine lactoferrin from the intestinal lumen into the systemic circulation via the portal vein and the mesenteric lymphatics in growing pigs. J. Vet. Med. Sci. 65: 567-572
125. Sfeir R. M., Dubarry M., Boyaka P. N., Rautureau M. and Tome D. (2004) The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. J. Nutr. 134: 403-409